Gang Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gang Wang has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Bo Diao
Department of Medical Laboratory Center, General Hospital of Central Theater Command, Wuhan, Hubei 430015, PR China
1 shared publication - Liping Wang
Basic Medical Laboratory General Hospital of the Central Theater Command Wuhan 430070 Hubei Province China
1 shared publication - Min Li
Basic Medical Laboratory General Hospital of the Central Theater Command Wuhan 430070 Hubei Province China
1 shared publication - Wenbin Song
People’s Hospital of Xinyang Xinyang 464000 Hennan Province China
1 shared publication - Ying Zhao
School of Medicine Wuhan University of Science and Technology Wuhan 430065 Hubei Province China wust.edu.cn
1 shared publication - Yueping Liu
Basic Medical Laboratory, General Hospital of Central Theater Command, Wuhan, China
1 shared publication
Latest Publications
- Open Access
- 12 May 2023
- Published by Wiley in Journal of Immunology Research
- Vol. 2023, 1-15
Exosome Derived from Human Umbilical Cord Mesenchymal Cell Exerts Immunomodulatory Effects on B Cells from SLE Patients
Background. Excessive proliferation and activation of B cells, resulting in the production of various autoantibodies, is a crucial link and significant feature of the pathogenesis of systemic lupus erythematosus (SLE), as well as the pathological basis of systemic multiorgan damage. However, whether exosomes derived from human umbilical cord mesenchymal stem cells (hucMSCs-Exo) are involved in the immune regulation of SLE has not been clarified. Objectives. Therefore, our study aimed to investigate the efficacy of hucMSCs-Exo for treating SLE. Methods. hucMSCs-Exo and peripheral blood mononuclear cells (PBMCs) of SLE patients were cocultured in vitro, and B cell apoptosis, activation, proliferation, and inflammation levels were detected by flow cytometry. Subsequently, the expression level of miR-155 in B lymphocytes of SLE patients was detected by qRT-PCR, and the target gene relationship between miR-155 and SHIP-1 was found through bioinformatics and dual luciferase activity experiments, which verified the inhibition of miR-155 in B lymphocytes of SLE patients to regulate immunity. Results. We found that hucMSCs-Exo promoted B cell apoptosis, prevented B cell overactivation, and reduced inflammation. MicroRNA-155 (miR-155) has a powerful regulatory function in B cells. It was demonstrated that hucMSCs-Exo acts synergistically with miR-155 inhibitors to target SHIP-1 to B cells more effectively than exosomes alone. Conclusion. Our results provide insight into how hucMSCs-Exo regulates autoimmunity in patients with lupus and suggest targeting miR-155 for autoimmunity while protecting immunity.
- 12 May 2023
- Published by Wiley in Journal of Immunology Research
- Vol. 2023, 1-15
Open AccessExosome Derived from Human Umbilical Cord Mesenchymal Cell Exerts Immunomodulatory Effects on B Cells from SLE Patients
Background. Excessive proliferation and activation of B cells, resulting in the production of various autoantibodies, is a crucial link and significant feature of the pathogenesis of systemic lupus erythematosus (SLE), as well as the pathological basis of systemic multiorgan damage. However, whether exosomes derived from human umbilical cord mesenchymal stem cells (hucMSCs-Exo) are involved in the immune regulation of SLE has not been clarified. Objectives. Therefore, our study aimed to investigate the efficacy of hucMSCs-Exo for treating SLE. Methods. hucMSCs-Exo and peripheral blood mononuclear cells (PBMCs) of SLE patients were cocultured in vitro, and B cell apoptosis, activation, proliferation, and inflammation levels were detected by flow cytometry. Subsequently, the expression level of miR-155 in B lymphocytes of SLE patients was detected by qRT-PCR, and the target gene relationship between miR-155 and SHIP-1 was found through bioinformatics and dual luciferase activity experiments, which verified the inhibition of miR-155 in B lymphocytes of SLE patients to regulate immunity. Results. We found that hucMSCs-Exo promoted B cell apoptosis, prevented B cell overactivation, and reduced inflammation. MicroRNA-155 (miR-155) has a powerful regulatory function in B cells. It was demonstrated that hucMSCs-Exo acts synergistically with miR-155 inhibitors to target SHIP-1 to B cells more effectively than exosomes alone. Conclusion. Our results provide insight into how hucMSCs-Exo regulates autoimmunity in patients with lupus and suggest targeting miR-155 for autoimmunity while protecting immunity.